isatuximab,carfilzomib,dexamethasone
Sanofi,amgen
['ikema', 'mmsm']
#ash22 presents the final pfs analysis of the phase 3 ikema study (nct03275285) confirming improved pfs compared with kd in rrmm. grade 3 and serious teae were similar in both arms in early relapse, but higher in the isa-kd arm in late relapse #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma